Ions to treat trauma and Covid-19
Award amount
$166,498Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- CHIMEROCYTE INC
- Proposal award date
- 2020-12-07
- Contract end date
- 2021-06-06
- UEI
- MRUSKCJLLEB7
- Solicitation number
- 20.B
- Topic code
- A20B-T028
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Iodide for the treatment of influenza and other stresses
- Highly Sensitive Chimerism Testing to Detect Early Leukemia Relapse Post-Allo-Transplantation
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- REDUCING COVID-19 MORTALITY BY CHARACTERIZING THE IMMUNOEPIGENETIC GUT MICROBIOME INTERACTIONS
- CoViRCureâ An Immunoprotective Oral Supplement for Reducing COVID-19 Post-Hyperimmunity Period Immune Suppression
Research funding history
3 SBIR/STTR records share this UEI (2018–2022). Reported award amounts total $1,566,075. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services